Previous research has suggested that the CP can be a promising therapeutic target for neurodegenerative disorders (i.e., protein misfolding diseases, such as AD and Parkinson’s disease) owing to its primary role in controlling the production and composition of CSF and the fact that harmful metabolites in the brain are eliminated through the CSF [32]. The gene discussed is CP; the disease is Parkinson disease.